Hydrodynamic Analysis on a Photocatalytic Reactor Using ANSYS Fluent^®

Solar technology includes a wide variety of developments in environmental applications that include photovoltaic cells and photocatalytic devices, among others. Sunlight usage as a clean energy source is highly desirable in technology applications. The main interest of this proposal is to carry on with hydrodynamic analysis in photocatalytic reactors applications where sunlight is used to activate a chemical reaction to degrade water pollutants and calculations are based in computational fluid dynamics (CFD) using ANSYS®. The different steps, geometric domain, preprocessing steps, setup, and postprocessing steps, are described to display an analysis of a numerical calculation during the design of a photocatalytic reactor using the commercial software ANSYS Fluent®. This work may help as a guide for chemical reactor design and includes a numerical solution of one case for a photocatalytic reactor during its design process. In addition, simplifications are explained which enable the designer to make an efficient process of the numerical calculation. Calculations and analysis are carried over in ANSYS Fluent® a powerful multi-physics program suite to develop photocatalytic reactors

A CFD Porous Materials Model to Test Soil Enriched with Nanostructured Zeolite Using ANSYS-Fluent⁽™⁾

Soil health is a great concern worldwide due to the huge variety of pollutants and human activities that may cause damage. There are different ways to remediate and make a better use of soil and a choice may be using zeolite in activities like gardening, farming, environment amending, among others. In this work is proposed a model to simulate how mixing zeolite with soil may be beneficial in different ways, we are especially interested in interactions of mixed soil-zeolite with water. This model is based in different flow regimes where water interacts with two layers formed by nanostructured zeolite and soil in a vertical arrangement. The analysis is approached as a bi-layer porous material model resolved by using the mathematical model implemented in ANSYS-Fluent. Such model uses a multi-fluid granular model to describe the flow behavior of a fluid–solid mixture where all the available interphase exchange coefficient models are empirically based. Despite the great capabilities of numerical simulation tools, it is known that at present time, the literature lacks a generalized formulation specific to resolve this kind of phenomena where a porous media is analyzed. This model is developed to obtain a systematic methodology to test nanomaterials with porous features produced in our laboratory which is the next step for near future work within our research group

Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City

Coronavirus disease 2019 (COVID-19) vaccines effectively protect against severe disease and death. However, the impact of the vaccine used, viral variants, and host factors on disease severity remain poorly understood. This work aimed to compare COVID-19 clinical presentations and outcomes in vaccinated and unvaccinated patients in Mexico City. From March to September 2021, clinical, demographic characteristics, and viral variants were obtained from 1014 individuals with a documented SARS-CoV-2 infection. We compared unvaccinated, partially vaccinated, and fully vaccinated patients, stratifying by age groups. We also fitted multivariate statistical models to evaluate the impact of vaccination status, SARS-CoV-2 lineages, vaccine types, and clinical parameters. Most hospitalized patients were unvaccinated. In patients over 61 years old, mortality was significantly higher in unvaccinated compared to fully vaccinated individuals. In patients aged 31 to 60 years, vaccinated patients were more likely to be outpatients (46%) than unvaccinated individuals (6.1%). We found immune disease and age above 61 years old to be risk factors, while full vaccination was found to be the most protective factor against in-hospital death. This study suggests that vaccination is essential to reduce mortality in a comorbid population such as that of Mexico

International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

•We report INICC device-associated module data of 50 countries from 2010-2015.•We collected prospective data from 861,284 patients in 703 ICUs for 3,506,562 days.•DA-HAI rates and bacterial resistance were higher in the INICC ICUs than in CDC-NHSN's.•Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's. Background: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. Methods: During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days. Results: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs. Conclusions: Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically